Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances.
Khayat
D
D
Medical Oncology Department, Salpetriére Hospital, Paris, France.
Coeffic
D
D
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007167:Immunotherapy; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis
D007155:Immunologic Factors; D016898:Interferon-alpha; D007376:Interleukin-2